#Australia #Sydney #Kirin Group #Cognizin #Blackmores

Exciting Launch of Cognizin® Cognitive Support Supplements by Kirin and Blackmores

The Kirin Group, in collaboration with Blackmores Limited, is thrilled to announce the launch of two cutting-edge cognitive support dietary supplements: Blackmores Cognition Ultra in Australia and Blackmores Ultra Brain Care in New Zealand. Set to hit the shelves in late July 2026, these innovative products feature Cognizin® Citicoline, a scientifically-backed ingredient designed to bolster memory, attention, and overall brain health.

Product Overview

The upcoming supplements mark a significant milestone as they represent the first products developed by Blackmores specifically aimed at enhancing cognitive function. This initiative is part of Kirin's ongoing commitment to advancing health science, leveraging insights from both Kirin Holdings and Blackmores to meet the health demands of consumers across the Asia-Pacific region.

What is Cognizin®?

Cognizin® is a patented form of Citicoline, known for its vital role in promoting brain health. Developed by Kyowa Hakko Bio Co., Ltd., Cognizin® has been clinically validated and is recognized for its ability to enhance cognitive functions such as focus, mental agility, and memory retention. The ingredient underscores the Kirin Group’s dedication to developing high-quality health solutions stemming from a deep understanding of nature and science.

Details of the Launch

The phased rollout for the supplements will begin with the launch on Blackmores’ official e-commerce platform in Australia by late July, followed by distribution through pharmacies starting September 2026. In New Zealand, consumers will find Blackmores Ultra Brain Care available through pharmacies from the same timeframe.

Both products contain 250 mg of Cognizin® Citicoline per tablet, with a recommendation of two tablets daily or as advised by a healthcare professional. Notably, these supplements are caffeine-free and designed not only to enhance cognitive performance but also to support brain functions vital to aging adults.

The Rationale Behind the Launch

As awareness regarding cognitive health grows, particularly related to aging, consumers increasingly seek effective solutions for maintaining and improving cognitive function. Alastair Symington, Senior Executive Officer of Kirin Holdings, highlighted the company’s purpose: “Our goal is to empower people’s long-term health by combining nature's best offerings with scientific advancements.”

Given that cognitive abilities play a crucial role in one’s overall quality of life, the introduction of these supplements is tailored to meet the needs of those seeking to support their brain health actively.

Market Implications

Following the announcement, the response from health-conscious consumers is anticipated to be positive, particularly amongst those who understand the importance of investing in brain health as they age. Blackmores Cognition Ultra and Blackmores Ultra Brain Care are not only timely but fundamentally address rising consumer demands for proactive health solutions in cognitive support.

Product Availability and Pricing

• - Blackmores Cognition Ultra (Australia): 30 tablets, AUD 45.00
• - Blackmores Ultra Brain Care (New Zealand): 30 tablets, NZD 41.99

Pricing may vary based on pharmacy retailers.

At a time when mental clarity and cognitive performance are of utmost importance, the Kirin Group and Blackmores are poised to provide innovative, effective solutions to enhance the lives of consumers across both nations.

For more information about these products and their benefits, visit Cognizin.com.